Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection.
Santos-Peral A, Luppa F, Goresch S, Nikolova E, Zaucha M, Lehmann L, Dahlstroem F, Karimzadeh H, Thorn-Seshold J, Winheim E, Schuster EM, Dobler G, Hoelscher M, Kümmerer BM, Endres S, Schober K, Krug AB, Pritsch M, Barba-Spaeth G, Rothenfusser S.
Santos-Peral A, et al. Among authors: rothenfusser s.
Nat Commun. 2024 Feb 24;15(1):1696. doi: 10.1038/s41467-024-45806-x.
Nat Commun. 2024.
PMID: 38402207
Free PMC article.